Healthy Lifestyle Could Prevent IBD Cases
Drug Topics
DECEMBER 30, 2022
New research indicates that inflammatory bowel disease (IBD) risk could be moderated by a healthy lifestyle.
Drug Topics
DECEMBER 30, 2022
New research indicates that inflammatory bowel disease (IBD) risk could be moderated by a healthy lifestyle.
IDStewardship
DECEMBER 30, 2022
On this webpage the Learn Antibiotics book is described. Where Can I Find The Learn Antibiotics Book? The Learn Antibiotics Book is currently available on Amazon and can be found here. Beware there has been at least one fake listing of the book on Amazon, which has been flagged for removal. Make sure to pick the listing that has Timothy P. Gauthier as the author.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Topics
DECEMBER 30, 2022
Take a look back at our most popular news from December 2022.
Pharmacy Times
DECEMBER 30, 2022
Products include the generic alternatives to Esbriet and Oracea.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Drug Topics
DECEMBER 30, 2022
Take a look back at the top 15 articles that we published in 2022.
Pharmacy Times
DECEMBER 30, 2022
This month's clinical pharmacology update looks at a medication to manage Helicobacter pylori infection in adults.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Compounding Pharmacy of America
DECEMBER 30, 2022
What vitamins support graceful aging and help to stay younger longer? Find vitamins to support longevity. The post Vitamins for Longevity and Youth appeared first on The Compounding Pharmacy of America.
STAT
DECEMBER 30, 2022
Francesca Coleman, known to friends as “St. Louis,” has been unhoused since the age of 15. Now 24, Coleman sleeps in Tongva park, across from the famous Santa Monica pier in California. Like many unhoused people in the Los Angeles area, Coleman uses meth in an attempt to ease chronic pain, anxiety, and depression. On a Wednesday morning in July, physician Coley King checked in with Coleman in Tongva Park.
pharmaphorum
DECEMBER 30, 2022
The vast majority of GPs are persuaded of the benefits of moving diagnostic services from the hospital to the community, according to a new survey of 200 GPs in the UK. Just 4% of would choose the hospital as the preferred location of testing, compared to 46% for the GP surgery, 18% for a community hub, 15% for a patient’s home and 12% for the pharmacy.
STAT
DECEMBER 30, 2022
This year, STAT deepened its footholds in a number of coverage areas, from hospitals and insurance to reproductive health to health tech. Our staff also looked with admiration — and some envy — to many other journalists doing great reporting in these spaces. Below is our annual list of STAT staffers’ favorite stories of the year, and that we wish we had written.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
pharmaphorum
DECEMBER 30, 2022
Speaking with Rob Verheul, CEO of Graphite Digital, at Anthropy 2022 at the Eden Project, pharmaphorum web editor Nicole Raleigh enjoyed a minute discussing the event and what specifically had attracted Verheul to attend. Chatting about Graphite Digital’s role as a design specialist for HCPs, patient groups, and ‘everything in between’ – the vision and purpose that encircles that – Verheul and I look at the conversations being sparked at the event, the challenges that are clear across industries
STAT
DECEMBER 30, 2022
The Food and Drug Administration’s approval of Wegovy, Novo Nordisk’s latest obesity drug, for adolescents aged 12 years and older opens up a highly-anticipated tool in the fight against childhood obesity, but some doctors warn the sought-after medication isn’t a magic bullet. The move comes after the FDA approved Wegovy (semaglutide) for weight management in adults in 2021.
Pharmacy Times
DECEMBER 30, 2022
New drug approvals, toxicity management, and pharmacists’ roles in cancer care all dominated the top oncology articles of 2022.
pharmaphorum
DECEMBER 30, 2022
The FDA’s interactions with Biogen in the build-up to last year’s controversial approval of Alzheimer’s disease therapy Aduhelm have been described as “inappropriate” and “atypical” in a congressional report on the review. The document produced by Oversight and Reform Committee chair Carolyn Maloney (D-NY) and Energy and Commerce Committee chair Frank Pallone Jr (D-NJ) also points to “collaboration” between Biogen and the FDA ahead of an advi
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
PharmExec
DECEMBER 30, 2022
AI continued to grow over the last year, and more life sciences companies are embracing the new technology in a variety of ways.
Pharmaceutical Commerce
DECEMBER 30, 2022
The latest people news happenings over the past month.
STAT
DECEMBER 30, 2022
Health care providers are swamping the government with billing disputes under the new law that bans surprise medical bills. So far, just 4% have ended in payment. That’s according to the Biden administration’s progress report on the No Surprises Act’s so-called independent dispute resolution (IDR) process, in which mediators help out-of-network providers and insurers decide appropriate payment amounts for services.
Let's personalize your content